Table 1—

Information about the definition of the metabolic syndrome used in studies of all-cause mortality, cardiovascular disease, and diabetes

Studies*NCEPModified NCEPChange madeWHOModified WHOChange made
Studies of all-cause mortality disease
    Lakka 2002XXNo impaired glucose tolerance, no microalbuminuria
    Katzmarzyk 2004X
    Hunt 2004XXUsed upper quartile of insulin concentration of nondiabetic participants, no microalbuminuria
    Ford 2004XMen: BMI ≥30; Women: BMI ≥25 kg/m2
Studies of cardiovascular disease
    Onat 2002X
    Lakka 2002XXNo impaired glucose tolerance, no microalbuminuria
    Resnick 2003X
    Katzmarzyk 2004X
    Bonora 2004XX
    Rutter 2004X
    Hunt 2004XXUsed upper quartile of insulin concentration of nondiabetic participants, no microalbuminuria
    McNeill 2004X
    Ridker 2003XWomen: BMI >26.7 kg/m2
    Sattar 2003XMen: BMI >28.8 kg/m2
    Girman 2004XMen: BMI >28.8; Women: BMI >26.2 kg/m2
    Ford 2004XMen: BMI ≥30; Women: BMI ≥25 kg/m2
    Isomaa 2001X
Studies of diabetes
    Laaksonen 2002XXNo impaired glucose tolerance, no microalbuminuria
    Resnick 2003X
    Sattar 2003XMen: BMI >28.8 kg/m2
    Lorenzo 2003XXNo impaired glucose tolerance, no microalbuminuria
    Stern 2004XNot stated
  • *

    * Studies are identified by author and year of published report.